Tag «Biocon»

IIMB alumni announce second edition of annual leadership summit IIMBue on Dec 17 & 18

Two-day event will bring together thought leaders including Piyush Goyal, Amitabh Kant, Javagal Srinath, Mohandas Pai, Deepika Padukone & IIMB’s alumni for a weekend of stimulating discussions on the theme ‘Start, Scale & Disrupt’ 09 December, 2016, Bengaluru: Industry titans, entrepreneurs, sportspersons, policy makers and actors, along with the alumni of Indian Institute of …

Thomson Reuters Analysis Identifies Hi-Tech Engineering and Pharma Companies as Front Runners of Innovation in India

Thomson Reuters 2014 State of Innovation India report analyzes innovation in 12 leading sectors based on patent activity for inventions originating from India Mumbai, December 12, 2014 – The Intellectual Property & Science business of Thomson Reuters, the world’s leading source of intelligent information for businesses and professionals, announced the launch of its 2014 …

ISB ANNOUNCES RESULTS OF ITS LARGEST AND FIRST ‘INTEGRATED’ PLACEMENTS

* Largest class comprising 762 students across Hyderabad and Mohali campuses * 21% increase in number of Participating Companies – 421 * · 27% increase in number of Offers – 798 Hyderabad/ Mohali, April 26, 2013: The Indian School of Business (ISB) today announced the placement results for the Class of 2013 of its Post …

Biocon announces that it has entered into an option agreement with Bristol-Myers Squibb for Biocon’s IN-105, an oral insulin drug candidate…

Biocon to continue development of IN-105 through Phase II; Bristol-Myers Squibb will have an exclusive option to further develop and commercialize IN-105, pending outcome of clinical trials Biocon announced today that it has entered into an option agreement with Bristol-Myers Squibb Company (NYSE: BMY) for Biocon’s IN-105, a prandial oral insulin product candidate. Under the …